## NDSN: Nordson Corporation - XLI: Industrials

### Executive Summary

No thesis match: MRS_10 0.5% below STRENGTH zone (3.0-6.0%); PEG 1.70 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: momentum weakening (-1.9% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($234.11)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 2
- **Sentiment:** Bullish (Bullish: 2, Bearish: 0)

**1. Nordson Corp. stock outperforms competitors on strong trading day**
- Source: MarketWatch | 20251222T171500 | Bullish | Relevance: 100%
- Nordson Corp. (NDSN) stock increased by 1.24% to $243.36 on a strong trading day for the overall market, outperforming the S&P 500 Index and the Dow Jones Industrial Average. This marks the stock's fourth consecutive day of gains.

**2. Here's Why It is Worth Investing in Nordson Stock Right Now**
- Source: TradingView â€” Track All Markets | 20251222T150918 | Bullish | Relevance: 100%
- Nordson Corporation (NDSN) is a strong investment due to its diversified business, focus on operational excellence, and strategic acquisitions. The company is experiencing growth in its Medical and Fluid Solutions segment and has expanded its medical offerings through the acquisition of Atrion Corp. Nordson also maintains shareholder-friendly policies, including significant dividend payments and share repurchases, and has seen upward revisions in earnings estimates.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 3, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-12 | DA Davidson | $290 | $285 | +2% |
| 2025-12-12 | Baird | $275 | $252 | +9% |
| 2025-12-11 | DA Davidson | $285 | $285 | 0% |
| 2025-12-11 | Keybanc | $295 | $250 | +18% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-12 | DA Davidson | main | Buy |
| 2025-12-12 | Baird | main | Neutral |
| 2025-12-11 | DA Davidson | main | Buy |
| 2025-12-11 | Keybanc | main | Overweight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 11 ($1.77M) |
| Sells | 12 ($3.60M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 41.0% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 2 / 8 |

**Top Holders:**
- Vanguard Group Inc: 10.8% (-2.1%)
- Blackrock Inc.: 6.8% (-0.3%)
- State Street Corpora: 5.1% (-3.2%)
- Kayne Anderson Rudni: 4.4% (-2.4%)
- Geode Capital Manage: 2.7% (+1.3%)

### Key Risks

1. Insider selling cluster: $3.6M in recent transactions.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Analyst target momentum: 3 raises (avg +10%) could attract flows.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 1.70 elevated, pricing in significant growth expectations. Forward P/E 20.3x stretched relative to 8% growth. Quality metrics strong (margin 17%). Analyst sentiment positive (3 raises, avg +10%). Insider selling cluster ($3.6M in 90 days), potential headwind. Institutional flow bullish (2 buying vs 8 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $13.6B |
| Beta | 1.02 |
| 52W Range | $165.03 - $251.47 |
| Short Interest | 2.8% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.70 |
| Forward P/E | 20.3 |
| Current P/E | 21.8 |
| YoY Growth | 7.6% |
| EPS Direction | STABLE |

### Technicals

MRS_10 deteriorating from 2.4% to 0.5% (-1.9% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 2.5pp (needs >3.0% for momentum thesis). MRS_5 (-0.2%) diverging from MRS_10 - short-term weakness emerging. Full SMA alignment bullish (above 20/50/200 SMAs). MACD histogram positive (0.63), confirming momentum. OFD pattern: +SLL (Support).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 0.48% (CS: 81) | Neutral |
| RSI_14 | 63.6 | Neutral |
| MACD Histogram | 0.63 | Bullish |
| vs SMA20 | 1.024x | Above |
| vs SMA50 | 1.036x | Above |
| vs SMA200 | 1.122x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $243.47
- **Stop Loss:** $234.11 (3.8% risk)
- **Target:** $252.83 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 96
- **Position Value:** $23,373.12
- **Portfolio %:** 23.37%
- **Risk Dollars:** $900.00
- **Risk Per Trade:** 0.90%
- **Modifiers:** L1 120% | L2 75% | Combined 0.90x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.20x |
| L2 Sector | WEAKENING (Zone B) | 0.75x |

*NORMAL regime with moderate risk appetite supported by year-end positioning. VIX at cycle lows (13.47) and multiple sectors hitting 52-week highs indicate constructive sentiment, though breadth at 57.9% suggests selectivity remains important. Fed pause expectations and stable macro backdrop support risk assets.*

### Earnings

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q4 | $2.93 | $3.03 | +3.4% |
| 2025Q3 | $2.64 | $2.73 | +3.5% |
| 2025Q2 | $2.36 | $2.42 | +2.6% |
| 2025Q1 | $2.08 | $2.06 | -0.9% |

---
*RULE-based L3 | 2026-01-06 16:38 | MRS_10*